A study sought to determine the reliability of the TNS-PV as a measure of potential vincristine-induced peripheral neuropathy in children with cancer treated with the agent.
In this study, the Disabilities of Arm, Shoulder and Hand (DASH) questionnaire was used to assess the impact of breast cancer treatment on the upper limb.
A literature search of new studies clarifies, refutes, and expands on previous recommendations for managing new and established CIPN in patients treated with cytotoxic agents.
Study sought to determine the degree of accuracy between patients’ reports and clinicians’ interpretation of CIPN symptoms.
Evidence from previous studies for patients with ovarian and endometrial cancers has suggested that goshajinkigan may treat and prevent CIPN.
Breast cancer patients on paclitaxel had lower incidence of peripheral neuropathy with cryotherapy, researchers found.
Use of multivitamins prior to a breast cancer diagnosis is associated with reduced symptoms of peripheral neuropathy.
Methadone appears to be superior to fentanyl for the treatment of neuropathic pain in patients with head and neck cancer.
The Indication for CTC ICPNQ is a valid instrument to distinguish the highest chemotherapy-induced peripheral neuropathy CTC grades from the lower CTC grades required to inform dose modification of chemotherapy decisions in clinical practice.
A study has found that duloxetine effectively decreases pain for patients with chemotherapy-related peripheral neuropathy, especially for those who received the drug as initial treatment.
